MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MP-20-0014474
Xena Formulations Private Limited
Xena Formulations Private Limited - pharma in Indore, Madhya Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹16.74 Lakh
Latest filing
Net loss · FY 2025
₹37,687
Net margin -2.3%
EBITDA · FY 2025
-₹37,687
EBITDA margin -2.3%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
of 2 registered
About Xena Formulations Private Limited
Data last updated:
Xena Formulations Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 December 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24230MP2019PTC050369. Its GSTIN is 23AAACX3143L2ZD (Madhya Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Bipin Kumar Pandey and Ritesh Sohgaura.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 151 Swami Dayanand Nagar, Indore, Madhya Pradesh, India – 452009.
As per the financials filed for FY 2025, the company reported a revenue of ₹16.74 Lakh. For the same year it recorded a net loss of ₹37,687 (net margin -2.3%) and EBITDA of -₹37,687 (EBITDA margin -2.3%).
Xena Formulations Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-20-0014474).
Company details
CIN U24230MP2019PTC050369
Registration Number 050369
Incorporation Date 16 December 2019
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MP-20-0014474
Recognitions & Rankings of Xena Formulations
Contact details
Xena Formulations Private Limited's registered office is in Indore, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address151 Swami Dayanand Nagar, Indore, Madhya Pradesh, India – 452009
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Xena Formulations Private Limited, buy the company report.
Comprehensive company report
Xena Formulations Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Xena Formulations Private Limited
FY 2025 filings availableXena Formulations Private Limited reported revenue of ₹16.74 Lakh for FY 2025.
Revenue · FY 2025
₹16.74 Lakh
Net loss · FY 2025
₹37,687 margin -2.3%
EBITDA · FY 2025
-₹37,687 margin -2.3%
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹37,687 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹37,687 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -2.3% | ||||
| Net Profit Margin | -2.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Xena Formulations Private Limited, buy the company report.
Board of directors of Xena Formulations Private Limited
Xena Formulations has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bipin Kumar Pandey Also directs: Xena Coronus Health Care Private Limited | Director | 16 Dec 2019 | 6 Years 10 Months | Current |
| Ritesh Sohgaura Also directs: Xena Coronus Health Care Private Limited | Director | 16 Dec 2019 | 6 Years 10 Months | Current |
Peer comparison
Xena Formulations Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Super Pneumatics Pvt Ltd | ₹16.98 Lakh (FY 2025) | 5.0% | New Delhi, Delhi, India | |||
| Ninai Life Sciences Private Limited | ₹16.87 Lakh (FY 2025) | -30.0% | Panvel, Maharashtra, India | |||
| Celestial Biolabs Limited | ₹16.87 Lakh (FY 2023) | 14.0% | Hyderabad, Telangana, India | |||
| Med-Interplast (India) Private Limited | ₹16.79 Lakh (FY 2022) | 2.0% | New Delhi, Delhi, India | |||
| Oyster Pharma Pvt Ltd | ₹16.77 Lakh (FY 2025) | -68.0% | Solan, Himachal Pradesh, India | |||
| Xena Formulations Private Limitedthis company | ₹16.74 Lakh (FY 2025) | -₹37,687 | -2.3% | Indore, Madhya Pradesh, India | ||
| Kumra Pharma Private Limited | ₹16.73 Lakh (FY 2024) | 321.0% | Delhi, India | |||
| Agrawal Medicaments Private Limited | ₹16.64 Lakh (FY 2024) | -28.0% | Margao, Goa, India | |||
| Navkar Formulation Pvt Ltd | ₹16.64 Lakh (FY 2019) | 1.0% | Ahmedabad, Gujarat, India | |||
| Chembricks Laboratories Private Limited | ₹16.58 Lakh (FY 2024) | Hyderabad, Telangana, India | ||||
| Napsko Healthcare Private Limited | ₹16.56 Lakh (FY 2024) | -46.0% | New Delhi, Delhi, India |
To see the full peer comparison of Xena Formulations Private Limited, buy the company report.
Auditor
Xena Formulations Private Limited is audited by SPJV&CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SPJV&CO | FY 2023 | 116884W |
Shareholding
The shareholding of Xena Formulations Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Xena Formulations Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Xena Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Xena Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Xena Formulations has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAACX3143L2ZD | Madhya Pradesh | Active | 28 Jan 2022 |
To see the full GST registrations and return filing status of Xena Formulations Private Limited, buy the company report.
Recent activity
Xena Formulations Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Bipin Kumar Pandey was appointed as Director on 16 Dec 2019.
AGM
Xena Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Xena Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Appointed
Bipin Kumar Pandey was appointed as Director.
Appointed
Ritesh Sohgaura was appointed as Director.
Incorporation
16 Dec 2019
Xena Formulations Private Limited was registered on 16 Dec 2019 with Roc Gwalior & aged 6 years 10 months as per MCA records.
Frequently asked questions
Xena Formulations is an active private limited company based in Indore, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 December 2019 (7+ years old) and is registered under CIN U24230MP2019PTC050369.
Xena Formulations has 2 current directors:
- Bipin Kumar Pandey - Director
- Ritesh Sohgaura - Director
The latest financial statements of Xena Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Xena Formulations is 23AAACX3143L2ZD, registered in Madhya Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Xena Formulations is U24230MP2019PTC050369. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Xena Formulations was incorporated on 16 December 2019, making it 7+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Xena Formulations by revenue are Super Pneumatics Pvt Ltd, Ninai Life Sciences Private Limited, Celestial Biolabs Limited, Med-Interplast (India) Private Limited, Oyster Pharma Pvt Ltd and 5 more, all in the Pharma industry (Formulations).
Bipin Kumar Pandey was appointed as Director on 16 Dec 2019. Ritesh Sohgaura was appointed as Director on 16 Dec 2019.
Yes, Xena Formulations is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-20-0014474).
The registered office of Xena Formulations is at 151 Swami Dayanand Nagar, Indore, Madhya Pradesh, India – 452009.
Xena Formulations operates in the pharma industry, in the drug formulation and development segment.